A Study of Mosunetuzumab in People With Follicular Lymphoma
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if mosunetuzumab is an effective treatment in people
with follicular lymphoma that was recently diagnosed and have not yet received any treatments
for their disease.